The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Karnell, Jodi L ^a   Ettinger, Rachel ^a  

^a MEDIMMUNE   (United States)

Author keywords

BAFF; BLys; Human B cell; IL 21

Indexed keywords

EID: 84874066172     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00002     Document Type: Review

References (76)

1. Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., and Sugamura, K. (2001). Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167, 1-5.
2. Avery, D. T., Bryant, V. L., Ma, C. S., de Waal Malefyt, R., and Tangye, S. G. (2008a). IL-21-induced iso-type switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181, 1767-1779.
3. Avery, D. T., Ma, C. S., Bryant, V. L., Santner-Nanan, B., Nanan, R., Wong, M., Fulcher, D. A., Cook, M. C., and Tangye, S. G. (2008b). STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood 112, 1784-1793.
4. Avery, D. T., Deenick, E. K., Ma, C. S., Suryani, S., Simpson, N., Chew, G. Y., Chan, T. D., Palendira, U., Bustamante, J., Boisson-Dupuis, S., Choo, S., Bleasel, K. E., Peake, J., King, C., French, M. A., Engelhard, D., Al-Hajjar, S., Al-Muhsen, S., Magdorf, K., Roesler, J., Arkwright, P. D., Hissaria, P., Riminton, D. S., Wong, M., Brink, R., Fulcher, D. A., Casanova, J. L., Cook, M. C., and Tangye, S. G. (2010). B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207, 155-171.
5. Avery, D. T., Kalled, S. L., Ellyard, J. I., Ambrose, C., Bixler, S. A., Thien, M., Brink, R., Mackay, F., Hodgkin, P. D., and Tangye, S. G. (2003). BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112, 286-297.
6. Badr, G., Borhis, G., Lefevre, E. A., Chaoul, N., Deshayes, F., Dessirier, V., Lapree, G., Tsapis, A., and Richard, Y. (2008). BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111, 2744-2754.
7. Becker-Merok, A., Nikolaisen, C., and Nossent, H. C. (2006). Blymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 15, 570-576.
8. Belnoue, E., Pihlgren, M., McGaha, T. L., Tougne, C., Rochat, A. F., Bossen, C., Schneider, P., Huard, B., Lambert, P. H., and Siegrist, C. A. (2008). APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111, 2755-2764.
9. Benson, M. J., Dillon, S. R., Castigli, E., Geha, R. S., Xu, S., Lam, K. P., and Noelle, R. J. (2008). Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J. Immunol. 180, 3655-3659.
10. Bernasconi, N. L., Traggiai, E., and Lanzavecchia, A. (2002). Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298, 2199-2202.
11. Bryant, V. L., Ma, C. S., Avery, D. T., Li, Y., Good, K. L., Corcoran, L. M., de Waal Malefyt, R., and Tangye, S. G. (2007). Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179, 8180-8190.
12. Cambridge, G., Isenberg, D. A., Edwards, J. C., Leandro, M. J., Migone, T. S., Teodorescu, M., and Stohl, W. (2008). B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann. Rheum. Dis. 67, 1011-1016.
13. Cambridge, G., Stohl, W., Leandro, M. J., Migone, T. S., Hilbert, D. M., and Edwards, J. C. (2006). Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum. 54, 723-732.
14. Cheema, G. S., Roschke, V., Hilbert, D. M., and Stohl, W. (2001). Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44, 1313-1319.
15. Chtanova, T., Tangye, S. G., Newton, R., Frank, N., Hodge, M. R., Rolph, M. S., and Mackay, C. R. (2004). T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173, 68-78.
16. Coquet, J. M., Kyparissoudis, K., Pellicci, D. G., Besra, G., Berzins, S. P., Smyth, M. J., and Godfrey, D. I. (2007). IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178, 2827-2834.
17. Craxton, A., Magaletti, D., Ryan, E. J., and Clark, E. A. (2003). Macrophage-and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101, 4464-4471.
18. Dall'Era, M., Chakravarty, E., Wallace, D., Genovese, M., Weisman, M., Kavanaugh, A., Kalunian, K., Dhar, P., Vincent, E., Pena-Rossi, C., and Wofsy, D. (2007). Reduced B lym-phocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis Rheum. 56, 4142-4150.
19. Darce, J. R., Arendt, B. K., Chang, S. K., and Jelinek, D. F. (2007a). Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J. Immunol. 178, 5612-5622.
20. Darce, J. R., Arendt, B. K., Wu, X., and Jelinek, D. F. (2007b). Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179, 7276-7286.
21. Davis, I. D., Skak, K., Smyth, M. J., Kristjansen, P. E., Miller, D. M., and Sivakumar, P. V. (2007). Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13, 6926-6932.
22. de Totero, D., Meazza, R., Zupo, S., Cutrona, G., Matis, S., Colombo, M., Balleari, E., Pierri, I., Fabbi, M., Capaia, M., Azzarone, B., Gobbi, M., Ferrarini, M., and Ferrini, S. (2006). Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood 107, 3708-3715.
23. Diehl, S. A., Schmidlin, H., Nagasawa, M., van Haren, S. D., Kwakkenbos, M. J., Yasuda, E., Beaumont, T., Scheeren, F. A., and Spits, H. (2008). STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180, 4805-4815.
24. Doreau, A., Belot, A., Bastid, J., Riche, B., Trescol-Biemont, M. C., Ranchin, B., Fabien, N., Cochat, P., Pouteil-Noble, C., Trolliet, P., Durieu, I., Tebib, J., Kassai, B., Ansieau, S., Puisieux, A., Eliaou, J. F., and Bonnefoy-Bérard, N. (2009). Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10, 778-785.
25. Dunn-Walters, D. K., Isaacson, P. G., and Spencer, J. (1995). Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182, 559-566.
26. Ettinger, R., Kuchen, S., and Lipsky, P. E. (2008a). Interleukin 21 as a target of intervention in autoimmune disease. Ann. Rheum. Dis. 67(Suppl. 3), iii83-iii86.
27. Ettinger, R., Kuchen, S., and Lipsky, P. E. (2008b). The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 223, 60-86.
28. Ettinger, R., Sims, G. P., Fairhurst, A. M., Robbins, R., da Silva, Y. S., Spolski, R., Leonard, W. J., and Lipsky, P. E. (2005). IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175, 7867-7879.
29. Ettinger, R., Sims, G. P., Robbins, R., Withers, D., Fischer, R. T., Grammer, A. C., Kuchen, S., and Lipsky, P. E. (2007). IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178, 2872-2882.
30. Good, K. L., Bryant, V. L., and Tangye, S. G. (2006). Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177, 5236-5247.
31. Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J., Mauri, D., Cavill, D., Gordon, T. P., Mackay, C. R., and Mackay, F. (2002). Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109, 59-68.
32. Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., Moore, M., Littau, A., Grossman, A., Haugen, H., Foley, K., Blumberg, H., Harrison, K., Kindsvogel, W., and Clegg, C. H. (2000). TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999.
33. Habib, T., Senadheera, S., Weinberg, K., and Kaushansky, K. (2002). The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41, 8725-8731.
34. Hagn, M., Ebel, V., Sontheimer, K., Schwesinger, E., Lunov, O., Beyer, T., Fabricius, D., Barth, T. F., Viardot, A., Stilgenbauer, S., Hepp, J., Scharffetter-Kochanek, K., Simmet, T., and Jahrsdörfer, B. (2010). CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. Eur. J. Immunol. 40, 2060-2069.
35. Hagn, M., Schwesinger, E., Ebel, V., Sontheimer, K., Maier, J., Beyer, T., Syrovets, T., Laumonnier, Y., Fabricius, D., Simmet, T., and Jahrsdorfer, B. (2009). Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J. Immunol. 183, 1838-1845.
36. Hagn, M., Sontheimer, K., Dahlke, K., Brueggemann, S., Kaltenmeier, C., Beyer, T., Hofmann, S., Lunov, O., Barth, T. F., Fabricius, D., Tron, K., Nienhaus, G. U., Simmet, T., Schrezenmeier, H., and Jahrsdörfer, B. (2011). Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol. Cell Biol. 1-11.
37. Jacobi, A. M., Huang, W., Wang, T., Freimuth, W., Sanz, I., Furie, R., Mackay, M., Aranow, C., Diamond, B., and Davidson, A. (2010). Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum. 62, 201-210.
38. Jahrsdorfer, B., Blackwell, S. E., Wooldridge, J. E., Huang, J., Andreski, M. W., Jacobus, L. S., Taylor, C. M., and Weiner, G. J. (2006). B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood 108, 2712-2719.
39. Jelinek, D. F., and Lipsky, P. E. (1985). The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells. J. Immunol. 134, 1690-1701.
40. Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C. M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., Wekerle, H., Hohlfeld, R., and Meinl, E. (2005). BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201, 195-200.
41. Kuchen, S., Robbins, R., Sims, G. P., Sheng, C., Phillips, T. M., Lipsky, P. E., and Ettinger, R. (2007). Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J. Immunol. 179, 5886-5896.
42. Lanzavecchia, A., and Sallusto, F. (2009). Human B cell memory. Curr. Opin. Immunol. 21, 298-304.
43. Lavie, F., Miceli-Richard, C., Ittah, M., Sellam, J., Gottenberg, J. E., and Mariette, X. (2007). Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Ann. Rheum. Dis. 66, 700-703.
44. Lin-Lee, Y. C., Pham, L.V., Tamayo, A. T., Fu, L., Zhou, H. J., Yoshimura, L. C., Decker, G. L., and Ford, R. J. (2006). Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes. J. Biol. Chem. 281, 18878-18887.
45. Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., and Cerutti, A. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829.
46. Massonnet, B., Delwail, A., Ayrault, J. M., Chagneau-Derrode, C., Lecron, J. C., and Silvain, C. (2009). Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Tolllike receptor 9 activation. Clin. Exp. Immunol. 158, 115-124.
47. Moore, P. A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. W., Feng, P., Soppet, D., Charters, M., Gentz, R., Parmelee, D., Li, Y., Galperina, O., Giri, J., Roschke, V., Nardelli, B., Carrell, J., Sosnovtseva, S., Greenfield, W., Ruben, S. M., Olsen, H. S., Fikes, J., and Hilbert, D. M. (1999). BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263.
48. Navarra, S. V., Guzman, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K., Thomas, M., Kim, H. Y., Leon, M. G., Tanasescu, C., Nasonov, E., Lan, J. L., Pineda, L., Zhong, Z. J., Freimuth, W., Petri, M. A., and BLISS-52 Study Group. (2011). Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377, 721-731.
49. Ng, L. G., Sutherland, A. P., Newton, R., Qian, F., Cachero, T. G., Scott, M. L., Thompson, J. S., Wheway, J., Chtanova, T., Groom, J., Sutton, I. J., Xin, C., Tangye, S. G., Kalled, S. L., Mackay, F., and Mackay, C. R. (2004). B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173, 807-817.
50. NovoNordisk. (2010). First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects with Rheumatoid Arthritis. Available at: http://clinicaltrials.gov/ct2/show/NCT01208506?term=IL-21&rank=11 Ident ifier: NCT01208506
51. Ozaki, K., Kikly, K., Michalovich, D., Young, P. R., and Leonard, W. J. (2000). Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc. Natl. Acad. Sci. U.S.A. 97, 11439-11444.
52. Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., Schrader, S., Burkhead, S., Heipel, M., Brandt, C., Kuijper, J. L., Kramer, J., Conklin, D., Presnell, S. R., Berry, J., Shiota, F., Bort, S., Hambly, K., Mudri, S., Clegg, C., Moore, M., Grant, F. J., Lofton-Day, C., Gilbert, T., Rayond, F., Ching, A., Yao, L., Smith, D., Webster, P., Whitmore, T., Maurer, M., Kaushansky, K., Holly, R. D., and Foster, D. (2000). Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408, 57-63.
53. Pene, J., Gauchat, J. F., Lecart, S., Drouet, E., Guglielmi, P., Boulay, V., Delwail, A., Foster, D., Lecron, J. C., and Yssel, H. (2004). Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172, 5154-5157.
54. Pene, J., Guglielmi, L., Gauchat, J. F., Harrer, N., Woisetschlager, M., Boulay, V., Fabre, J. M., Demoly, P., and Yssel, H. (2006). IFN-gamma-mediated inhibition of human IgE synthesis by IL-21 is associated with a polymorphism in the IL-21R gene. J. Immunol. 177, 5006-5013.
55. Pfizer. (2010). Study to Assess the Safety and Tolerability of Increasing Single Doses of ATR-107 (PF-05230900) in Healthy People. Available at: http://clinicaltrials.gov/ct2/show/NCT01162889?term=ATR-107&rank=1 Identifier: NCT01162889
56. Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E. C., Ware, C. F., Fairchild, R. L., Omori, S. A., Rickert, R. C., Scott, M., Kotzin, B. L., and Li, X. (2004). Act1, a negative regulator in CD40-and BAFF-mediated B cell survival. Immunity 21, 575-587.
57. Rahman, Z. S., Rao, S. P., Kalled, S. L., and Manser, T. (2003). Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J. Exp. Med. 198, 1157-1169.
58. Rasheed, A. U., Rahn, H. P., Sallusto, F., Lipp, M., and Muller, G. (2006). Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 36, 1892-1903.
59. Scapini, P., Nardelli, B., Nadali, G., Calzetti, F., Pizzolo, G., Montecucco, C., and Cassatella, M. A. (2003). G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197, 297-302.
60. Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. H., Browning, J. L., and Tschopp, J. (1999). BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756.
61. Scholz, J. L., Crowley, J. E., Tomayko, M. M., Steinel, N., O'Neill, P. J., Quinn, W. J. III, Goenka, R., Miller, J. P., Cho, Y. H., Long, V., Ward, C., Migone, T. S., Shlomchik, M. J., and Cancro, M. P. (2008). BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc. Natl. Acad. Sci. U.S.A. 105, 15517-15522.
62. Sims, G. P., Ettinger, R., Shirota, Y., Yarboro, C. H., Illei, G. G., and Lipsky, P. E. (2005). Identification and characterization of circulating human transitional B cells. Blood 105, 4390-4398.
63. Spolski, R., and Leonard, W. J. (2008a). Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57-79.
64. Spolski, R., and Leonard, W. J. (2008b). The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20, 295-301.
65. Spolski, R., and Leonard, W. J. (2010). IL-21 and T follicular helper cells. Int. Immunol. 22, 7-12.
66. Tak, P. P., Thurlings, R. M., Rossier, C., Nestorov, I., Dimic, A., Mircetic, V., Rischmueller, M., Nasonov, E., Shmidt, E., Emery, P., and Munafo, A. (2008). Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single-and repeated-dose study. Arthritis Rheum. 58, 61-72.
67. Tangye, S. G., Liu, Y. J., Aversa, G., Phillips, J. H., and de Vries, J. E. (1998). Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188, 1691-1703.
68. Thompson, J. S., Bixler, S. A., Qian, F., Vora, K., Scott, M. L., Cachero, T. G., Hession, C., Schneider, P., Sizing, I. D., Mullen, C., Strauch, K., Zafari, M., Benjamin, C. D., Tschopp, J., Browning, J. L., and Ambrose, C. (2001). BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293, 2108-2111.
69. Thompson, J. S., Schneider, P., Kalled, S. L., Wang, L., Lefevre, E. A., Cachero, T. G., MacKay, F., Bixler, S. A., Zafari, M., Liu, Z. Y., Woodcock, S. A., Qian, F., Batten, M., Madry, C., Richard, Y., Benjamin, C. D., Browning, J. L., Tsapis, A., Tschopp, J., and Ambrose, C. (2000). BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192, 129-135.
70. Wallace, D. J., Stohl, W., Furie, R. A., Lisse, J. R., McKay, J. D., Merrill, J. T., Petri, M. A., Ginzler, E. M., Chatham, W. W., McCune, W. J., Fernandez, V., Chevrier, M. R., Zhong, Z. J., and Freimuth, W. W. (2009). A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 61, 1168-1178.
71. Webb, R., Merrill, J. T., Kelly, J. A., Sestak, A., Kaufman, K. M., Langefeld, C. D., Ziegler, J., Kimberly, R. P., Edberg, J. C., Ramsey-Goldman, R., Petri, M., Reveille, J. D., Alarcón, G. S., Vilá, L. M., Alarcón-Riquelme, M. E., James, J. A., Gilkeson, G. S., Jacob, C. O., Moser, K. L., Gaffney, P. M., Vyse, T. J., Nath, S. K., Lipsky, P., Harley, J. B., and Sawalha, A. H. (2009). A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum. 60, 2402-2407.
72. Weill, J. C., Weller, S., and Reynaud, C. A. (2009). Human marginal zone B cells. Annu. Rev. Immunol. 27, 267-285.
73. Weller, S., Reynaud, C. A., and Weill, J. C. (2005). Splenic marginal zone B cells in humans: where do they mutate their Ig receptor? Eur. J. Immunol. 35, 2789-2792.
74. Wong, C. K., Wong, P. T., Tam, L. S., Li, E. K., Chen, D. P., and Lam, C. W. (2010). Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J. Clin. Immunol. 30, 45-52.
75. Wood, N., Bourque, K., Donaldson, D. D., Collins, M., Vercelli, D., Goldman, S. J., and Kasaian, M. T. (2004). IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell. Immunol. 231, 133-145.
76. Zhang, X., Park, C. S., Yoon, S. O., Li, L., Hsu, Y. M., Ambrose, C., and Choi, Y. S. (2005). BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int. Immunol. 17, 779-788.